FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2565991256> ?p ?o ?g. }

• W2565991256 endingPage "2196" @default.
• W2565991256 startingPage "2187" @default.
• W2565991256 abstract "// Qiyu Zhao 1 , Guo Tian 2 , Fen Chen 3 , Liyun Zhong 1 and Tian’an Jiang 1 1 Department of Ultrasonography, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou China 2 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 3 Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China Correspondence to: Tian’an Jiang, email: // Keywords : laser ablation; CT-guided; computed tomography; lung; lung cancer Received : September 02, 2016 Accepted : November 22, 2016 Published : December 10, 2016 Abstract Objective: To report the efficacy and safety of CT-guided percutaneous laser ablation (PLA) for metastatic lung tumors. Methods: Three cases of metastatic lung cancer underwent CT-guided PLA, and we searched for previously published articles on the minimally invasive CT-guided RFA or MWA for lung tumors in recent five years. Results: With the guidance of CT, all lesions had good prognosis under laser ablation. Case 1 suffering from severe pulmonary dysfunction and diffuse pulmonary bullae, had small pneumothorax. CT scan obtained four months following the ablation showed two lesions had complete responses and one partial response. Case 2 had successful complete response with absent lung mass, and also had a good postoperative condition without any discomfort in the two-month follow-up. Case 3 showed partial response and improved greatly after five months. 962 cases (mean age of 45.7 years, 62.2% male) of 1297 lung tumors with detailed information were identified from 27 articles. Of these cases, the minority manifested complications such as pneumothorax, hemoptysis, hemothorax, pneumonia, pain and fever. Conclusions: Percutaneous CT-guided PLA could be a safe and promising minimally invasive treatment for patients with primary lung cancer or unresectable pulmonary metastases, especially multineedle PLA in large tumors, which still needs more large-scale prospective studies to convince this method in the future." @default.
• W2565991256 created "2017-01-06" @default.
• W2565991256 creator A5008047814 @default.
• W2565991256 creator A5015166339 @default.
• W2565991256 creator A5016874780 @default.
• W2565991256 creator A5055084879 @default.
• W2565991256 creator A5069088823 @default.
• W2565991256 date "2016-12-10" @default.
• W2565991256 modified "2023-09-26" @default.
• W2565991256 title "CT-guided percutaneous laser ablation of metastatic lung cancer: three cases report and literature review" @default.
• W2565991256 cites W1493459210 @default.
• W2565991256 cites W1679341568 @default.
• W2565991256 cites W1727037638 @default.
• W2565991256 cites W1931814657 @default.
• W2565991256 cites W1935225233 @default.
• W2565991256 cites W1943972344 @default.
• W2565991256 cites W1973169868 @default.
• W2565991256 cites W1978940762 @default.
• W2565991256 cites W1982517271 @default.
• W2565991256 cites W1994500967 @default.
• W2565991256 cites W2008737845 @default.
• W2565991256 cites W2021819338 @default.
• W2565991256 cites W2049076088 @default.
• W2565991256 cites W2075396790 @default.
• W2565991256 cites W2078576049 @default.
• W2565991256 cites W2089727253 @default.
• W2565991256 cites W2109320726 @default.
• W2565991256 cites W2112391258 @default.
• W2565991256 cites W2124918900 @default.
• W2565991256 cites W2131566306 @default.
• W2565991256 cites W2136188495 @default.
• W2565991256 cites W2146255603 @default.
• W2565991256 cites W2150920602 @default.
• W2565991256 cites W2150996515 @default.
• W2565991256 cites W2162213969 @default.
• W2565991256 cites W2165174880 @default.
• W2565991256 cites W2178926956 @default.
• W2565991256 cites W2208603708 @default.
• W2565991256 cites W2271389674 @default.
• W2565991256 cites W2278187937 @default.
• W2565991256 cites W2287104745 @default.
• W2565991256 cites W2299154791 @default.
• W2565991256 cites W2315264434 @default.
• W2565991256 cites W2323096433 @default.
• W2565991256 cites W2329089513 @default.
• W2565991256 cites W2329167883 @default.
• W2565991256 cites W2339199266 @default.
• W2565991256 cites W2397954194 @default.
• W2565991256 cites W2462343785 @default.
• W2565991256 cites W2516737171 @default.
• W2565991256 cites W2519181333 @default.
• W2565991256 cites W2524081300 @default.
• W2565991256 cites W3208519847 @default.
• W2565991256 cites W369848585 @default.
• W2565991256 doi "https://doi.org/10.18632/oncotarget.13901" @default.
• W2565991256 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5356791" @default.
• W2565991256 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27974695" @default.
• W2565991256 hasPublicationYear "2016" @default.
• W2565991256 type Work @default.
• W2565991256 sameAs 2565991256 @default.
• W2565991256 citedByCount "14" @default.
• W2565991256 countsByYear W25659912562017 @default.
• W2565991256 countsByYear W25659912562018 @default.
• W2565991256 countsByYear W25659912562019 @default.
• W2565991256 countsByYear W25659912562020 @default.
• W2565991256 countsByYear W25659912562021 @default.
• W2565991256 countsByYear W25659912562022 @default.
• W2565991256 countsByYear W25659912562023 @default.
• W2565991256 crossrefType "journal-article" @default.
• W2565991256 hasAuthorship W2565991256A5008047814 @default.
• W2565991256 hasAuthorship W2565991256A5015166339 @default.
• W2565991256 hasAuthorship W2565991256A5016874780 @default.
• W2565991256 hasAuthorship W2565991256A5055084879 @default.
• W2565991256 hasAuthorship W2565991256A5069088823 @default.
• W2565991256 hasBestOaLocation W25659912561 @default.
• W2565991256 hasConcept C126322002 @default.
• W2565991256 hasConcept C126838900 @default.
• W2565991256 hasConcept C141071460 @default.
• W2565991256 hasConcept C2776256026 @default.
• W2565991256 hasConcept C2777377203 @default.
• W2565991256 hasConcept C2777714996 @default.
• W2565991256 hasConcept C2778329176 @default.
• W2565991256 hasConcept C2778902805 @default.
• W2565991256 hasConcept C2780813298 @default.
• W2565991256 hasConcept C71924100 @default.
• W2565991256 hasConceptScore W2565991256C126322002 @default.
• W2565991256 hasConceptScore W2565991256C126838900 @default.
• W2565991256 hasConceptScore W2565991256C141071460 @default.
• W2565991256 hasConceptScore W2565991256C2776256026 @default.
• W2565991256 hasConceptScore W2565991256C2777377203 @default.
• W2565991256 hasConceptScore W2565991256C2777714996 @default.
• W2565991256 hasConceptScore W2565991256C2778329176 @default.
• W2565991256 hasConceptScore W2565991256C2778902805 @default.
• W2565991256 hasConceptScore W2565991256C2780813298 @default.
• W2565991256 hasConceptScore W2565991256C71924100 @default.
• W2565991256 hasIssue "2" @default.
• W2565991256 hasLocation W25659912561 @default.
• W2565991256 hasLocation W25659912562 @default.

• next